0001213900-23-097821.txt : 20231221
0001213900-23-097821.hdr.sgml : 20231221
20231221205445
ACCESSION NUMBER: 0001213900-23-097821
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231221
FILED AS OF DATE: 20231221
DATE AS OF CHANGE: 20231221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Valentine Troy
CENTRAL INDEX KEY: 0001998126
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41106
FILM NUMBER: 231506964
MAIL ADDRESS:
STREET 1: 105 / 8 CENTURY CIRCUIT
CITY: NORWEST, NSW
STATE: C3
ZIP: 2153
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Incannex Healthcare Inc.
CENTRAL INDEX KEY: 0001873875
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: C3
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 401 DOCKLANDS DRIVE
STREET 2: SUITE 15, LEVEL 12
CITY: DOCKLANDS, VICTORIA
STATE: C3
ZIP: 3008
BUSINESS PHONE: 61 409 840 786
MAIL ADDRESS:
STREET 1: 401 DOCKLANDS DRIVE
STREET 2: SUITE 15, LEVEL 12
CITY: DOCKLANDS, VICTORIA
STATE: C3
ZIP: 3008
FORMER COMPANY:
FORMER CONFORMED NAME: Incannex Healthcare Ltd
DATE OF NAME CHANGE: 20210720
4
1
ownership.xml
X0508
4
2023-12-21
0
0001873875
Incannex Healthcare Inc.
IXHL
0001998126
Valentine Troy
105 / 8 CENTURY CIRCUIT
NORWEST, NEW SOUTH WALES
C3
2153
AUSTRALIA
1
0
0
0
0
Common Stock
2023-12-21
4
A
0
670000
0
A
699250
D
Common Stock
10000
I
By Mr. Valentine as the beneficiary of the GFCR Investments Trust
Common Stock
30000
I
By Valplan Pty Ltd, a company of which Mr. Valentine is a director
Common Stock
10000
I
By Tranaj Nominees Pty Ltd, a company of which Mr. Valentine is a director
Common Stock
242862
I
By Alignment Capital Pty Ltd, a company of which Mr. Valentine is a director and major shareholder
Common Stock
44400
I
By Cityside Pty Ltd, a company wholly-owned by Mr. Valentine
Award of restricted stock of which 167,500 shares will vest on December 31, 2023, 167,500 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 167,500 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 167,500 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date.
/s/ Troy Valentine
2023-12-21